Find out more about our cost-effective immunoassay panel, which uses oral fluid testing to support addiction treatment and pain management.
Connect with us at the American Academy of Neurology Annual Meeting to learn how our evaluations can inform your clinical practice.
A new comprehensive genetic panel redefines Parkinson's disease diagnosis - Insights
Mayo Clinic Laboratories introduces the Inherited Parkinson’s Disease Gene Panel (Mayo ID: PARDP), a collaborative breakthrough poised to transform Parkinson’s disease diagnosis and treatment. Led by Rodolfo Savica, M.D., Ph.D., and Zhiyv...
Mayo Clinic Labs @Work: Paul Schneider - Insights
As a national accounts executive for Mayo Clinic Laboratories, Paul Schneider helps to improve and advance diagnostic patient care by bringing Mayo Clinic Laboratories testing to many of the nation’s top health care systems.
Skip to Content MayoACCESS MayoLINK...
Find out how our unique tests, methodologies, and reference ranges provide fast, accurate results for complex pediatric gastroenterology conditions.
Unveiling a novel hemoglobinopathy classification - Insights
In a recent discovery by Mayo Clinic Laboratories, a novel hemoglobinopathy category was identified and termed epsilon gamma thalassemia. The first instance of the disorder was found in 2017 when an obstetric patient underwent a routine...
Frequently Asked Questions - Mayo Clinic Laboratories
Frequently Asked Questions Ordering Tests Collecting and Preparing Your Specimen Do you accept animal specimens?...
Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score - Insights
In this month’s “Hot Topic,” Divyanshu Dubey, M.B.B.S., discusses how patients with encephalopathy and/or epilepsy of unknown etiology may have an autoimmune or paraneoplastic cause.
Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score - Insights
In this month’s “Hot Topic,” Divyanshu Dubey, M.B.B.S., discusses how patients with encephalopathy and/or epilepsy of unknown etiology may have an autoimmune or paraneoplastic cause.
See how our innovative evaluations detect multiple sclerosis with increased sensitivity to put patients on the correct diagnostic pathway.
Mayo Clinic Labs @Work: Kimberly Knight - Insights
As a national accounts executive for Mayo Clinic Laboratories, Kimberly Knight helps clients see and understand the importance of laboratory testing and how partnering with Mayo Clinic Laboratories on that testing can help them and their...
Antimicrobial Crisis: A Silent Threat Claiming Lives - Insights from Dr. Robin Patel - Insights
Globally, five million deaths are associated with bacterial antimicrobial resistance each year, but the complexity of the issue is there is no single solution because we need to use antibiotics. It’s about finding a different way to live...
Jeff Meeusen, Ph.D., a clinical chemist and Co-Director of Cardiovascular Laboratory Medicine at Mayo Clinic in Rochester, recently authored an article in Clinical Laboratory News that discusses patient fasting in lipid testing. While...
Transforming clinical practice and changing outcomes for brain tumor patients - Insights
The genetic variability of glioma, and its more advanced relative glioblastoma, has made genetic testing to identify biomarkers associated with prognosis and treatment effectivity an integral component of care plan development. However, the...
Mayo Clinic Laboratories’ comprehensive dementia testing menu includes evaluations for Alzheimer's disease, autoimmune dementia, and rapidly progressive dementia.
Applying the Staffing-to-Workload Methodology: Identifying Daily Indirect Effort Needs - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, demonstrates how daily indirect effort tasks contribute to staffing plans and needs in the staffing-to-workload methodology.
Long and Winding Road Leads to Mayo-and a "Miracle" - Insights
In April 2018, Frank Lonabaugh was driving when his hand slid down the steering wheel. Odd, he thought. Unusual. And looking back, the first sign of a problem that would lead Frank and his wife, Christine, from their home in Fort Myers,...
For people with encephalitis, rapid treatment of their acute brain inflammation is critical for avoiding devastating physical and cognitive deficits. But appropriate treatment requires identifying the culprit causing the symptoms.
Industry Archives - Page 3 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
CPT Codes and LOINC Update: June 2019 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of June 2019.
Assay identifies rare tick-borne bacteria: Bobbi Pritt, M.D. - Insights
Bobbi Pritt, M.D., explains how Mayo Clinic Laboratories' new assay identifies less-common tick-borne bacteria in whole blood. The assay is recommended when tick-borne bacterial infection is suspected but standard testing is unrevealing.
Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D. - Insights
Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost...
Therapeutics events - Insights
TherapeuticS Creating the new standard of therapeutic management, together Mayo Clinic Laboratories’ evidence-based toxicology and pharmacogenomic testing
Mayo Clinic Laboratories’ commitment to pediatric care is supported by over 150 years of experience informing diagnoses and treatment plans.
Research Roundup Archives - Page 27 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Page 28 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Bile acid malabsorption - Insights
Chronic diarrhea and abdominal pain can be caused by many conditions, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Celiac disease, infectious GI pathogens, and malignancy. When other causes of chronic diarrhea...
Cayuga Medical Center: Building a world-class lab that drives revenue - Insights
Cayuga Medical Center sought to challenge the narrative that a hospital’s lab is an expensive liability by positioning themselves as the laboratory of choice in their area.
Expanded colorectal cancer panel tests more genes - Insights
Mayo Clinic Laboratories has developed a new colorectal cancer test, the MayoComplete Colorectal Cancer Panel (Mayo ID: MCCRC), in response to the latest recommendations for testing and treatment from the American Society of Clinical...
Dr. Robin Patel shares periprosthetic joint infection findings in NEJM - Insights
The New England Journal of Medicine recently published new findings on periprosthetic joint infection by Dr. Robin Patel.
In an article about "titans who defined a new era in business during the last decade," former Mayo Clinic President and CEO John Noseworthy, M.D., looked back on his tenure with gratitude.
Five steps for successful outreach program implementation - Insights
Learn the five elements essential to successfully implementing a complex outreach program project and what is at risk if you miss an element.
Mayo Clinic Laboratory and Pathology Research Roundup: March 12 - Insights
This week's research roundup feature: C3 glomerulopathy (C3G) is a rare disease resulting from dysregulation of the alternative pathway of complement. C3G includes C3 glomerulonephritis (C3GN) and dense...
NMMC Selects Mayo Medical Laboratories for Advanced Laboratory Testing Needs - Insights
North Mississippi Medical Center has selected Mayo Medical Laboratories as its primary reference laboratory.
Specialized testing diagnoses uncommon allergy to red meat: Joseph Ducaji - Insights
CT scans and hiatal/abdominal ultrasounds could not uncover why, whenever he ate steak, Joseph Ducaji experienced severe stomach problems, itchy hives, chills, and nausea. It took specialized testing from Mayo Clinic to unlock a...
Direct immunofluorescence for autoimmune bullous diseases - Insights
In this month’s “Hot Topic,” Julia Lehman, M.D., discusses a recent change to the direct immunofluorescence assay, specifically the addition of the IgG4 conjugate.
Krabbe disease added to federal newborn screening panel - Insights
Thanks to advocacy work by a group of medical experts, including some from Mayo Clinic, the U.S. Department of Health and Human Services now recommends all states screen for infantile Krabbe disease to help save newborn lives.
acute_leukemias_of_ambiguous_lineage_testing_algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 01/2025 Acute Leukemias of Ambiguous Lineage Testing Algorithm Order the following: ■ LCMS / Leukemia/Lymphoma Immunophenotyping, Flow Cytometry, Varies ■...
Present Approaches to Testing - Insights
Discussing current test applications that you can implement in your laboratory or practice today.
Mayo Clinic Laboratories cerebrospinal fluid metagenomic testing uses shotgun metagenomic sequencing to interrogate all microbial DNA and RNA present in a sample and determine the presence of potential pathogens.
Laboratory testing utilization: Coccidioides immitis/posadasii serologic testing - Insights
In this month's "Hot Topic," Elitza Theel, Ph.D., shares the recommended approach to serologic testing for assessment or infection with coccidioides.
CPT Codes and LOINC Update: Jan. 2019 - Insights
The list of updates posted to mayocliniclabs.com during the month of January 2019 are now available.
Laboratory Utilization Management: Tick-Borne Disease Testing - Insights
In this month's "Hot Topic," Elitza Theel, Ph.D., will be discussing laboratory utilization management, specifically for diagnostic testing for tick-borne diseases.
Research Archives - Page 11 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
Developed through evidence-driven clinical innovation and designed to deliver clarity on drug and alcohol use, our testing delivers results that advance understanding and improve outcomes.
Mayo Clinic Laboratory and Pathology Research Roundup: March 19 - Insights
This week's research roundup feature: The revised 4th edition of the World Health Organization (WHO4R) classification lists myelodysplastic syndromes with ring sideroblasts (MDS-RS) as a separate entity...
Week in Review: January 20 - Insights
Topic highlights include: Phoenix Children’s opens specialty clinic at Avondale campus, Moderna says RSV vaccine is effective in older adults, WHO questions severity of XBB.1.5 COVID subvariant as U.S. cases rise
William Morice II, M.D., Ph.D., discusses progress in COVID-19 vaccine development - Insights
In a story on Washington D.C. Fox 5 News, Dr. Morice reviewed the significance of reports that a COVID-19 vaccine was found to be more than 90% effective.
Week in Review: March 31 - Insights
Today's Highlights Include: US FDA seeks to allow salt substitutes in everyday foods, radioactive water leaks at Minn. nuclear plant for 2nd time, and pushback grows over mental health impacts of social media.